Business Wire

TINUBU-SQUARE

15.12.2020 15:02:15 CET | Business Wire | Press release

Share
Tinubu® Square’s Acquisition of SuretyWave Streamlines Agent-Carrier Surety Tech Connection

Tinubu® Square Group, the global technology leader in the surety and credit insurance industry, announced today it has acquired the assets of SuretyWave LLC, including its technology and knowledge base, notably the cloud-based surety bond processing system known as SurePath Digital.

The acquisition continues Tinubu Square’s execution of its global strategic vision of building highly complementary and integrated enterprise software solutions and services for credit and surety insurers. This enables clients, brokers, agents, obligees, and carriers to manage their rapidly evolving, high-growth businesses efficiently.

With the acquisition, Tinubu Square’s end-to-end SaaS platform simplifies processing for an entire value chain that has long struggled with disparate, complex surety bond information. Agents, brokers and carrier partners can now efficiently manage their bond requirements, premiums, commission and other calculations.

Tinubu Square is the global leader in designing, producing and servicing the largest providers of financial guarantee products. The Paris-based firm provides technology solutions to 30 of the top 60 credit and surety underwriters in the United States and globally.

Jérôme Pezé, co-founder and CEO, says, “We are now even closer to a global promise of full automation and digitalization of surety and credit insurance products.”

SurePath Digital “is an outstanding insurtech solution because of its proven ability to streamline connections for independent agencies and brokers, which are key business partners to carriers that stand behind bonds,” Pezé adds. “These bond producers add significant value for customers, but desperately need the appropriate technology solution for their business to reduce manual processing, be more efficient for their customers, and grow profitably.”

Earlier this year, Tinubu Square acquired another U.S.-based insurtech, eSURETY®, which provides cloud-based solutions for automated underwriting, account risk analysis, bond lifecycle management and surety analytics at an enterprise level.

“The Tinubu eSURETY solution, its team’s expertise, and its brand recognition brought highly complementary capabilities to our combined existing and future customers,” says Pezé. “What that platform provides for surety carriers, SurePath Digital does for agents and brokers. SurePath significantly reduces the cost of executing and managing surety bonds through automation of administration, processing and reporting functions.

“These capabilities have strengthened our position in the global surety marketplace, providing an end-to-end cloud-based platform,” Pezé adds.

Daniel T. Buckles, deputy CEO and president, surety, of Tinubu Square Americas, notes that the surety bond business “is highly complex but too often still paper-based for multiline agents and brokers and their carrier partners. SurePath Digital is the key to continue to make it less cumbersome so our partners can focus on completing deals. We are building technology bridges in the surety industry where there have been none.”

“We are excited for SurePath Digital to be aligned with an industry leader in Tinubu Square,” says W. Patrick McGinty CPCU, president of SuretyWave. “Existing clients of Tinubu eSURETY and SuretyWave continue to be in safe hands, as the companies concentrate on sustainability and continuity for their software users. Tinubu Square has the same determined focus, innovative technology, and customer-centricity that provide a best-in-class customer experience and product.”

Olivier Placca, Tinubu Square co-founder and group deputy CEO, states, “By investing 20% of revenue in research and development on a yearly basis, Tinubu Square will support further innovation for the benefit of SurePath Digital’s clients. It reinforces our commitment to making this a long-term partnership.”

Placca adds: “Our solution can grow and make an even more significant positive impact in the surety business. Tinubu Square’s enterprise solutions lead the way in supporting an open ecosystem for all players in the surety and credit insurance industry. We are reducing the duplication of tasks, including the many manual tasks still in use. This reduces administrative costs, improves processes and operations, and eases the two-way communication between brokers and agents with underwriters.”

About SuretyWave
In 2017, Steckler Group acquired Insure Vision Technologies (IVT) and renamed the company as SuretyWave. IVT, founded in 1999, was formed to develop a cloud-based surety bond processing system that significantly reduces the cost of executing and managing surety bonds. IVT founders Pam Stocks and Bev Hall helped lead surety industry efforts by being active with ACORD’s standard setting committee for electronic interface between carriers and brokers/agents and with the National Association of Surety Bond Producers (NASBP) Surety Automation Committee and Commercial Surety Committee.

About Tinubu Square
Tinubu® Square is the industry-leading insurtech SaaS (software as a service) platform vendor, enabling credit insurance and surety digital transformation. With 170+ employees globally and 20 years of innovation, Tinubu Square empowers its customers to offer best-in-class client experience; reduce exposure to risk; and lower financial, operational and technology costs. The firm has a footprint with customers in over 20 countries, including 30 of the top 60 worldwide credit and surety underwriters and invests 20% of its annual revenue in research and development. Visit www.tinubu.com/ for more information.

Link:

ClickThru

Social Media:

https://www.facebook.com/tinubu.square.35

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release

If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids

Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release

Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use

DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release

-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating

HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release

HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi

Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release

Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye